Chaperoning heat shock proteins: Proteomic analysis and relevance for normal and dystrophin-deficient muscle

Proteomics - Clinical Applications

Volumn 8, Issue 11-12, 2014, Pages 875-895

  Brinkmeier, Heinrich ^a   Ohlendieck, Kay ^b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Chaperone; Dystrophin; Heat shock protein; Muscular dystrophy; Stress response

Indexed keywords

ALPHA B CRYSTALLIN; ALPHA CRYSTALLIN; CARDIOVASCULAR HEAT SHOCK PROTEIN; CHAPERONIN 60; DESMIN; DJ 1 PROTEIN; DYSTROPHIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 5; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 71; HEAT SHOCK PROTEIN 72; HEAT SHOCK PROTEIN 75; HEAT SHOCK PROTEIN 8; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN B1; HEAT SHOCK PROTEIN B10; HEAT SHOCK PROTEIN B7; UNCLASSIFIED DRUG; VIMENTIN; BIOLOGICAL MARKERS; HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; PROTEOME;

ADAPTATION; AMYOTROPHIC LATERAL SCLEROSIS; BIOCHEMISTRY; BIOLOGICAL FUNCTIONS; CONGENITAL MOTOR NEUROPATHY; DUCHENNE MUSCULAR DYSTROPHY; DYSFERLINOPATHY; DYSTROPHINOPATHY; GEL FREE SHOTGUN PROTEOMICS; HIGH THROUGHPUT COMPARATIVE PROTEOMICS; HUMAN; HYPOKALEMIC MYOPATHY; INSULIN RESISTANCE; LIMB GIRDLE MUSCULAR DYSTROPHY; METABOLIC MYOPATHY; MUSCLE DEVELOPMENT; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; MYASTHENIA GRAVIS; MYOFIBRILLAR MYOPATHY; MYOTONIC DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEOMICS; REVIEW; SEPSIS; SKELETAL MUSCLE; SPINAL MUSCULAR ATROPHY; X LINKED MUSCULAR DYSTROPHY; HUMANS; METABOLISM; METHODS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; HEAT-SHOCK PROTEINS; HUMANS; MOLECULAR CHAPERONES; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84912573454     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201400015     Document Type: Review

References (234)

1. Hartl, F. U., Bracher, A., Hayer-Hartl, M., Molecular chaperones in protein folding and proteostasis. Nature 2011, 475, 324-332.
2. Verschuure, P., Tatard, C., Boelens, W. C., Grongnet, J. F., David, J. C., Expression of small heat shock proteins HspB2, HspB8, Hsp20 and cvHsp in different tissues of the perinatal developing pig. Eur. J. Cell Biol. 2003, 82, 523-530.
3. Golenhofen, N., Perng, M. D., Quinlan, R. A., Drenckhahn, D., Comparison of the small heat shock proteins alphaB-crystallin, MKBP, HSP25, HSP20, and cvHSP in heart and skeletal muscle. Histochem. Cell Biol. 2004, 122, 415-425.
4. Fink, A. L., Chaperone-mediated protein folding. Physiol. Rev. 1999, 79, 425-449.
5. Nishimura, R. N., Sharp, F. R., Heat shock proteins and neuromuscular disease. Muscle Nerve 2005, 32, 693-709.
6. Kim, Y. E., Hipp, M. S., Bracher, A., Hayer-Hartl, M., Hartl, F. U., Molecular chaperone functions in protein folding and proteostasis. Annu. Rev. Biochem. 2013, 82, 323-355.
7. Vos, M. J., Hageman, J., Carra, S., Kampinga, H. H., Structural and functional diversities between members of the human HSPB, HSPH, HSPA, and DNAJ chaperone families. Biochemistry 2008, 47, 7001-7011.
8. Kampinga, H. H., Hageman, J., Vos, M. J., Kubota, H. et al., Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 2009, 14, 105-111.
9. Liu, Y., Steinacker, J. M., Changes in skeletal muscle heat shock proteins: pathological significance. Front. Biosci. 2001, 6, D12-D25.
10. Liu, Y., Gampert, L., Nething, K., Steinacker, J. M., Response and function of skeletal muscle heat shock protein 70. Front. Biosci. 2006, 11, 2802-2827.
11. Morton, J. P., Kayani, A. C., McArdle, A., Drust, B., The exercise-induced stress response of skeletal muscle, with specific emphasis on humans. Sports Med. 2009, 39, 643-662.
12. Crawford, G. L., Horowits, R., Scaffolds and chaperones in myofibril assembly: putting the striations in striated muscle. Biophys. Rev. 2011, 3, 25-32.
13. Senf, S. M., Skeletal muscle heat shock protein 70: diverse functions and therapeutic potential for wasting disorders. Front. Physiol. 2013, 4, 330.
14. Rabindran, S. K., Giorgi, G., Clos, J., Wu, C., Molecular cloning and expression of a human heat shock factor, HSF1. Proc. Natl. Acad. Sci. USA 1991, 88, 6906-6910.
15. Amin, J., Ananthan, J., Voellmy, R., Key features of heat shock regulatory elements. Mol. Cell. Biol. 1988, 8, 3761-3769.
16. Anckar, J., Sistonen, L., Heat shock factor 1 as a coordinator of stress and developmental pathways. Adv. Exp. Med. Biol. 2007, 594, 78-88.
17. Morton, J. P., MacLaren, D. P., Cable, N. T., Bongers T. et al., Time course and differential responses of the major heat shock protein families in human skeletal muscle following acute nondamaging treadmill exercise. J. Appl. Physiol. 2006, 101, 176-182.
18. Oishi, Y., Imoto, K., Ogata, T., Taniguchi, K. et al., Calcineurin and heat-shock proteins modulation in clenbuterol-induced hypertrophied rat skeletal muscles. Pflügers Arch. 2004, 448, 114-122.
19. Morton, J. P., Maclaren, D. P., Cable, N. T., Campbell, I. T. et al., Trained men display increased basal heat shock protein content of skeletal muscle. Med. Sci. Sports Exerc. 2008, 40, 1255-1262.
20. Ishihara, A., Fujino, H., Nagatomo, F., Takeda, I., Ohira, Y., Gene expression levels of heat shock proteins in the soleus and plantaris muscles of rats after hindlimb suspension or spaceflight. J. Physiol. Sci. 2008, 58, 413-417.
21. Huey, K. A., Burdette, S., Zhong, H., Roy, R. R., Early response of heat shock proteins to functional overload of the soleus and plantaris in rats and mice. Exp. Physiol. 2010, 95, 1145-1155.
22. Lawler, J. M., Kwak, H. B., Kim, J. H., Lee, Y. et al., Biphasic stress response in the soleus during reloading after hind limb unloading. Med. Sci. Sports Exerc. 2012, 44, 600-609.
23. McArdle, A., Jackson, M. J., Exercise, oxidative stress and ageing. J. Anat. 2000, 197, 539-541.
24. Holland, A., Carberry, S., Ohlendieck, K., Proteomics of the dystrophin-glycoprotein complex and dystrophinopathy. Curr. Protein Pept. Sci. 2013, 14, 680-697.
25. van Montfort, R., Slingsby, C., Vierling, E., Structure and function of the small heat shock protein/alpha-crystallin family of molecular chaperones. Adv. Protein Chem. 2001, 59, 105-156.
26. Narberhaus, F., Alpha-crystallin-type heat shock proteins: socializing minichaperones in the context of a multichaperone network. Microbiol. Mol. Biol. Rev. 2002, 66, 64-93.
27. Merck, K. B., Horwitz, J., Kersten, M., Overkamp, P. et al., Comparison of the homologous carboxy-terminal domain and tail of alpha-crystallin and small heat shock protein. Mol. Biol. Rep. 1993, 18, 209-215.
28. Baranova, E. V., Weeks, S. D., Beelen, S., Bukach, O. V. et al., Three-dimensional structure of α-crystallin domain dimers of human small heat shock proteins HSPB1 and HSPB6. J. Mol. Biol. 2011, 411, 110-122.
29. Boelens, W. C., Cell biological roles of αB-crystallin. Prog. Biophys. Mol. Biol. 2014, DOI: 10.1016/j.pbiomolbio.2014.02.005. in press.
30. Stamler, R., Kappe, G., Boelens, W., Slingsby, C., Wrapping the alpha-crystallin domain fold in a chaperone assembly. J. Mol. Biol. 2005, 353, 68-79.
31. de Jong, W. W., Leunissen, J. A., Voorter, C. E., Evolution of the alpha-crystallin/small heat-shock protein family. Mol. Biol. Evol. 1993, 10, 103-126.
32. Kappe, G., Franck, E., Verschuure, P., Boelens, W. C. et al., The human genome encodes 10 alpha-crystallin-related small heat shock proteins: HspB1-10. Cell Stress Chaperones 2003, 8, 53-61.
33. Sun, X., Fontaine, J. M., Rest, J. S., Shelden, E. A. et al., Interaction of human HSP22 (HSPB8) with other small heat shock proteins. J. Biol. Chem. 2004, 279, 2394-2402.
34. Fontaine, J. M., Sun, X., Benndorf, R., Welsh, M. J., Interactions of HSP22 (HSPB8) with HSP20, alphaB-crystallin, and HSPB3. Biochem. Biophys. Res. Commun. 2005, 337, 1006-1011.
35. Horwitz, J., The function of alpha-crystallin in vision. Semin. Cell Dev. Biol. 2000, 11, 53-60.
36. Litt, M., Kramer, P., LaMorticella, D. M., Murphey, W. et al., Autosomal dominant congenital cataract associated with a missense mutation in the human alpha crystallin gene CRYAA. Hum. Mol. Genet. 1998, 7, 471-474.
37. Clark, J. I., Self-assembly of protein aggregates in ageing disorders: the lens and cataract model. Philos. Trans. R Soc. Lond. B Biol. Sci. 2013, 368, 20120104.
38. Dubin, R. A., Wawrousek, E. F., Piatigorsky, J., Expression of the murine alpha B-crystallin gene is not restricted to the lens. Mol. Cell. Biol. 1989, 9, 1083-1089.
39. Iwaki, T., Kume-Iwaki, A., Goldman, J. E., Cellular distribution of alpha B-crystallin in non-lenticular tissues. J. Histochem. Cytochem. 1990, 38, 31-39.
40. Oertel, M. F., May, C. A., Bloemendal, H., Lutjen-Drecoll, E., Alpha-B-crystallin expression in tissues derived from different species in different age groups. Ophthalmologica 2000, 214, 13-23.
41. Iwaki, T., Iwaki, A., Goldman, J. E., Alpha B-crystallin in oxidative muscle fibers and its accumulation in ragged-red fibers: a comparative immunohistochemical and histochemical study in human skeletal muscle. Acta Neuropathol. 1993, 85, 475-480.
42. Mymrikov, E. V., Seit-Nebi, A. S., Gusev, N. B. Large potentials of small heat shock proteins. Physiol. Rev. 2011, 91, 1123-1159.
43. Nicholl, I. D., Quinlan, R. A., Chaperone activity of alpha-crystallins modulates intermediate filament assembly. EMBO J. 1994, 13, 945-953.
44. Neufer, P. D., Benjamin I. J., Differential expression of B-crystallin and Hsp27 in skeletal muscle during continuous contractile activity. Relationship to myogenic regulatory factors. J. Biol. Chem. 1996, 271, 24089-24095.
45. Neufer, P. D., Ordway, G. A., Williams, R. S., Transient regulation of c-fos, alpha B-crystallin, and hsp70 in muscle during recovery from contractile activity. Am. J. Physiol. 1998, 274, C341-C346.
46. Sakurai, T., Fujita, Y., Ohto, E., Oguro, A., Atomi, Y., The decrease of the cytoskeleton tubulin follows the decrease of the associating molecular chaperone alphaB-crystallin in unloaded soleus muscle atrophy without stretch. FASEB J. 2005, 19, 1199-1201.
47. Melkani, G. C., Cammarato, A., Bernstein, S. I., Alpha-B-crystallin maintains skeletal muscle myosin enzymatic activity and prevents its aggregation under heat-shock stress. J. Mol. Biol. 2006, 358, 635-645.
48. Jee, H., Sakurai, T., Kawada, S., Ishii, N., Atomi, Y., Significant roles of microtubules in mature striated muscle deduced from the correlation between tubulin and its molecular chaperone alphaB-crystallin in rat muscles. J. Physiol. Sci. 2009, 59, 149-155.
49. Sugiyama, Y., Suzuki, A., Kishikawa, M., Akutsu, R. et al., Muscle develops a specific form of small heat shock protein complex composed of MKBP/HSPB2 and HSPB3 during myogenic differentiation. J. Biol. Chem. 2000, 275, 1095-1104.
50. Singh, B. N., Rao, K. S., Rao, C. M., Ubiquitin-proteasome-mediated degradation and synthesis of MyoD is modulated by alphaB-crystallin, a small heat shock protein, during muscle differentiation. Biochim. Biophys. Acta 2010, 1803, 288-299.
51. Adhikari, A. S., Rao, K. S., Rangaraj, N., Parnaik, V. K., Rao, C. M., Heat stress-induced localization of small heat shock proteins in mouse myoblasts: intranuclear lamin A/C speckles as target for alphaB-crystallin and Hsp25. Exp. Cell Res. 2004, 299, 393-403.
52. Vicart, P., Caron, A., Guicheney, P., Li, Z. et al., Missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat. Genet. 1998, 20, 92-95.
53. Clemen, C. S., Herrmann, H., Strelkov, S. V., Schröder, R., Desminopathies: pathology and mechanisms. Acta Neuropathol. 2013, 125, 47-75.
54. Sanbe, A., Molecular mechanisms of α-crystallinopathy and its therapeutic strategy. Biol. Pharm. Bull. 2011, 34, 1653-1658.
55. Irobi, J., Van Impe, K., Seeman, P., Jordanova, A. et al., Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat. Genet. 2004, 36, 597-601.
56. Capponi, S., Geroldi, A., Fossa, P., Grandis, M. et al., HSPB1 and HSPB8 in inherited neuropathies: study of an Italian cohort of dHMN and CMT2 patients. J. Peripher. Nerv. Syst. 2011, 16, 287-294.
57. Rossor, A. M., Polke, J. M., Houlden, H., Reilly, M. M., Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat. Rev. Neurol. 2013, 9, 562-571.
58. Doran, P., Gannon, J., O'Connell, K., Ohlendieck, K., Aging skeletal muscle shows a drastic increase in the small heat shock proteins alphaB-crystallin/HspB5 and cvHsp/HspB7. Eur. J. Cell Biol. 2007, 86, 629-640.
59. Doran, P., Donoghue, P., O'Connell, K., Gannon, J., Ohlendieck, K., Proteomics of skeletal muscle aging. Proteomics 2009, 9, 989-1003.
60. Hageman, J., van Waarde, M. A., Zylicz, A., Walerych, D., Kampinga, H. H., The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities. Biochem. J. 2011, 435, 127-142.
61. Hernando, R., Manso, R., Muscle fibre stress in response to exercise: synthesis, accumulation and isoform transitions of 70-kDa heat-shock proteins. Eur. J. Biochem. 1997, 243, 460-467.
62. González, B., Hernando, R., Manso, R., Anabolic steroid and gender-dependent modulation of cytosolic HSP70s in fast- and slow-twitch skeletal muscle. J. Steroid Biochem. Mol. Biol. 2000, 74, 63-71.
63. Ogata, T., Oishi, Y., Higashida, K., Higuchi, M., Muraoka, I., Prolonged exercise training induces long-term enhancement of HSP70 expression in rat plantaris muscle. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296, R1557-R1563.
64. Duguez, S., Bihan, M. C., Gouttefangeas, D., Féasson, L., Freyssenet, D., Myogenic and nonmyogenic cells differentially express proteinases, Hsc/Hsp70, and BAG-1 during skeletal muscle regeneration. Am. J. Physiol. Endocrinol. Metab. 2003, 285, E206-E215.
65. Ogata, T., Oishi, Y., Roy, R. R., Ohmori, H., Endogenous expression and developmental changes of HSP72 in rat skeletal muscles. J. Appl. Physiol. 2003, 95, 1279-1286.
66. Noble, E. G., Milne, K. J., Melling, C. W., Heat shock proteins and exercise: a primer. Appl. Physiol. Nutr. Metab. 2008, 33, 1050-1065.
67. Murlasits, Z., Cutlip, R. G., Geronilla, K. B., Rao, K. M. et al., Resistance training increases heat shock protein levels in skeletal muscle of young and old rats. Exp. Gerontol. 2006, 41, 398-406.
68. Vasilaki, A., Jackson, M. J., McArdle, A., Attenuated HSP70 response in skeletal muscle of aged rats following contractile activity. Muscle Nerve 2002, 25, 902-905.
69. McArdle, A., Vasilaki, A., Jackson, M., Exercise and skeletal muscle ageing: cellular and molecular mechanisms. Ageing Res. Rev. 2002, 1, 79-93.
70. Broome, C. S., Kayani, A. C., Palomero, J., Dillmann, W. H. et al., Effect of lifelong overexpression of HSP70 in skeletal muscle on age-related oxidative stress and adaptation after nondamaging contractile activity. FASEB J. 2006, 20, 1549-1551.
71. McArdle, A., Dillmann, W. H., Mestril, R., Faulkner, J. A., Jackson, M. J., Overexpression of HSP70 in mouse skeletal muscle protects against muscle damage and age-related muscle dysfunction. FASEB J. 2004, 18, 355-357.
72. Kurucz, I., Morva, A., Vaag, A., Eriksson, K. F., Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance. Diabetes 2002, 51, 1102-1109.
73. Bruce, C. R., Carey, A. L., Hawley, J. A., Febbraio, M. A., Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defence mechanism. Diabetes 2003, 52, 2338-2345.
74. Geiger, P. C., Gupte, A. A., Heat shock proteins are important mediators of skeletal muscle insulin sensitivity. Exerc. Sport Sci. Rev. 2011, 39, 34-42.
75. De Paepe, B., Creus, K. K., Martin, J. J., Weis, J., De Bleecker, J. L., A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages. Ann. NY Acad. Sci. 2009, 1173, 463-469.
76. Liao, Y., Hung, M. C., Physiological regulation of Akt activity and stability. Am. J. Transl. Res. 2010, 2, 19-42.
77. Andres-Mateos, E., Brinkmeier, H., Burks, T. N., Mejias, R. et al., Activation of serum/glucocorticoid-induced kinase 1 (SGK1) is important to maintain skeletal muscle homeostasis and prevent atrophy. EMBO Mol. Med. 2013, 5, 80-91.
78. Li, J., Buchner, J., Structure, function and regulation of the hsp90 machinery. Biomed J. 2013, 36, 106-117.
79. Ohlendieck, K., Proteomic identification of biomarkers of skeletal muscle disorders. Biomarkers Med. 2013, 7, 169-186.
80. Højlund, K., Yi, Z., Hwang, H., Bowen, B. et al., Characterization of the human skeletal muscle proteome by one-dimensional gel electrophoresis and HPLC-ESI-MS/MS. Mol. Cell. Proteomics 2008, 7, 257-267.
81. Raddatz, K., Albrecht, D., Hochgräfe, F., Hecker, M., Gotthardt, M., A proteome map of murine heart and skeletal muscle. Proteomics 2008, 8, 1885-1897.
82. Parker, K. C., Walsh, R. J., Salajegheh, M., Amato, A. A. et al., Characterization of human skeletal muscle biopsy samples using shotgun proteomics. J. Proteome Res. 2009, 8, 3265-3277.
83. 12 myoblasts and fully differentiated myotubes reveal the complexity of the skeletal muscle differentiation program. Mol. Cell. Proteomics 2004, 3, 1065-1082.
84. Gonnet, F., Bouazza, B., Millot, G. A., Ziaei, S. et al., Proteome analysis of differentiating human myoblasts by dialysis-assisted two-dimensional gel electrophoresis (DAGE). Proteomics 2008, 8, 264-278.
85. Henningsen, J., Rigbolt, K. T., Blagoev, B., Pedersen, B. K., Kratchmarova, I., Dynamics of the skeletal muscle secretome during myoblast differentiation. Mol. Cell. Proteomics 2010, 9, 2482-2496.
86. Okumura, N., Hashida-Okumura, A., Kita, K., Matsubae, M. et al., Proteomic analysis of slow- and fast-twitch skeletal muscles. Proteomics 2005, 5, 2896-2906.
87. Capitanio, D., Vigano, A., Ricci, E., Cerretelli P. et al., Comparison of protein expression in human deltoideus and vastus lateralis muscles using two-dimensional gel electrophoresis. Proteomics 2005, 5, 2577-2586.
88. Drexler, H. C., Ruhs, A., Konzer, A., Mendler, L. et al., On marathons and Sprints: an integrated quantitative proteomics and transcriptomics analysis of differences between slow and fast muscle fibers. Mol. Cell. Proteomics 2013, 11, M111.010801.
89. Burniston, J. G., Changes in the rat skeletal muscle proteome induced by moderate-intensity endurance exercise. Biochim. Biophys. Acta 2008, 1784, 1077-1086.
90. Yamaguchi, W., Fujimoto, E., Higuchi, M., Tabata, I., A DIGE proteomic analysis for high-intensity exercise-trained rat skeletal muscle. J. Biochem. 2010, 148, 327-333.
91. Gandra, P. G., Valente, R. H., Perales, J., Pacheco, A. G., Macedo, D. V., Proteomic profiling of skeletal muscle in an animal model of overtraining. Proteomics 2012, 12, 2663-2667.
92. Roca-Rivada, A., Al-Massadi, O., Castelao, C., Senín, L. L. et al., Muscle tissue as an endocrine organ: comparative secretome profiling of slow-oxidative and fast-glycolytic rat muscle explants and its variation with exercise. J. Proteomics 2012, 75, 5414-5425.
93. Donoghue, P., Doran, P., Dowling, P., Ohlendieck, K., Differential expression of the fast skeletal muscle proteome following chronic low-frequency stimulation. Biochim. Biophys. Acta 2005, 1752, 166-176.
94. Donoghue, P., Doran, P., Wynne, K., Pedersen, K., et al., Proteomic profiling of chronic low-frequency stimulated fast muscle. Proteomics 2007, 7, 3417-3430.
95. Ohlendieck, K., Proteomic profiling of skeletal muscle plasticity. Muscles Ligaments Tendons J. 2012, 1, 119-126.
96. Oh, T. S., Choi, J. W., Choi, D. K., Mukherjee, R. et al., Gender dimorphism in skeletal muscle proteome between lean and diet-induced obese rats. Cell. Physiol. Biochem. 2011, 28, 981-996.
97. Hamelin, M., Sayd, T., Chambon, C., Bouix, J. et al., Proteomic analysis of ovine muscle hypertrophy. J. Anim. Sci. 2006, 84, 3266-3276.
98. Seo, Y., Lee, K., Park, K., Bae, K., Choi, I., A proteomic assessment of muscle contractile alterations during unloading and reloading. J. Biochem. 2006, 139, 71-80.
99. Sun, H., Liu, J., Ding, F., Wang, X., Investigation of differentially expressed proteins in rat gastrocnemius muscle during denervation-reinnervation. J. Muscle Res. Cell. Motil. 2006, 27, 241-250.
100. Sun, H., Li, M., Gong, L., Liu, M. et al., iTRAQ-coupled 2D LC-MS/MS analysis on differentially expressed proteins in denervated tibialis anterior muscle of Rattus norvegicus. Mol. Cell. Biochem. 2012, 364, 193-207.
101. Piec, I., Listrat, A., Alliot, J., Chambon, C., Differential proteome analysis of aging in rat skeletal muscle. FASEB J. 2005, 19, 1143-1145.
102. O'Connell, K., Gannon, J., Doran, P., Ohlendieck, K., Proteomic profiling reveals a severely perturbed protein expression pattern in aged skeletal muscle. Int. J. Mol. Med. 2007, 20, 145-153.
103. Doran, P., O'Connell, K., Gannon, J., Kavanagh, M., Ohlendieck, K., Opposite pathobiochemical fate of pyruvate kinase and adenylate kinase in aged rat skeletal muscle as revealed by proteomic DIGE analysis. Proteomics 2008, 8, 364-377.
104. Feng, J., Xie, H., Meany, D. L., Thompson, L. V. et al., Quantitative proteomic profiling of muscle type-dependent and age-dependent protein carbonylation in rat skeletal muscle mitochondria. J. Gerontol. A Biol. Sci. Med. Sci. 2008, 63, 1137-1152.
105. Bosworth, C. A., Chou, C. W., Cole, R. B., Rees, B. B., Protein expression patterns in zebrafish skeletal muscle: initial characterization and the effects of hypoxic exposure. Proteomics 2005, 5, 1362-1371.
106. De Palma, S., Morandi, L., Mariani, E., Begum, S. et al., Proteomic investigation of the molecular pathophysiology of dysferlinopathy. Proteomics 2006, 6, 379-385.
107. Sela, I., Milman Krentsis, I., Shlomai, Z., Sadeh, M. et al., The proteomic profile of hereditary inclusion body myopathy. PLoS One 2011, 6, e16334.
108. Feldkirchner, S., Schessl, J., Müller, S., Schoser, B., Hanisch, F. G., Patient-specific protein aggregates in myofibrillar myopathies: laser microdissection and differential proteomics for identification of plaque components. Proteomics 2012, 12, 3598-3609.
109. Kley, R. A., Maerkens, A., Leber, Y., Theis, V. et al., A combined laser microdissection and mass spectrometry approach reveals new disease relevant proteins accumulating in aggregates of filaminopathy patients. Mol. Cell. Proteomics 2013, 12, 215-227.
110. Maerkens, A., Kley, R. A., Olivé, M., Theis, V. et al., Differential proteomic analysis of abnormal intramyoplasmic aggregates in desminopathy. J. Proteomics 2013, 90, 14-27.
111. Mutsaers, C. A., Lamont, D. J., Hunter, G., Wishart, T. M., Gillingwater, T. H., Label-free proteomics identifies Calreticulin and GRP75/Mortalin as peripherally accessible protein biomarkers for spinal muscular atrophy. Genome Med. 2013, 5, 95.
112. Gomez, A. M., Vanheel, A., Losen, M., Molenaar, P. C. et al., Proteomic analysis of rat tibialis anterior muscles at different stages of experimental autoimmune myasthenia gravis. J. Neuroimmunol. 2013, 261, 141-145.
113. Staunton, L., Jockusch, H., Wiegand, C., Albrecht, T., Ohlendieck, K., Identification of secondary effects of hyperexcitability by proteomic profiling of myotonic mouse muscle. Mol. Biosyst. 2011, 7, 2480-2489.
114. Capitanio, D., Vasso, M., Ratti, A., Grignaschi, G. et al., Molecular signatures of amyotrophic lateral sclerosis disease progression in hind and forelimb muscles of an SOD1(G93A) mouse model. Antioxid. Redox Signal. 2012, 17, 1333-1350.
115. Thongboonkerd, V., Kanlaya, R., Sinchaikul, S., Parichatikanond, P. et al., Proteomic identification of altered proteins in skeletal muscle during chronic potassium depletion: implications for hypokalemic myopathy. J. Proteome Res. 2006, 5, 3326-3335.
116. Hwang, H., Bowen, B. P., Lefort, N., Flynn, C. R. et al., Proteomics analysis of human skeletal muscle reveals novel abnormalities in obesity and type 2 diabetes. Diabetes 2010, 59, 33-42.
117. Mullen, E., O'Reilly, E., Ohlendieck, K., Skeletal muscle tissue from the Goto-Kakizaki rat model of type-2 diabetes exhibits increased levels of the small heat shock protein Hsp27. Mol. Med. Rep. 2011, 4, 229-236.
118. Thingholm, T. E., Bak, S., Beck-Nielsen, H., Jensen, O. N., Gaster, M., Characterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods. Mol. Cell. Proteomics 2011, 10, M110.006650.
119. Yuan, H., Niu, Y., Liu, X., Yang, F. et al., Proteomic analysis of skeletal muscle in insulin-resistant mice: response to 6-week aerobic exercise. PLoS One 2013, 8, e53887.
120. Duan, X., Berthiaume, F., Yarmush, D., Yarmush, M. L., Proteomic analysis of altered protein expression in skeletal muscle of rats in a hypermetabolic state induced by burn sepsis. Biochem. J. 2006, 397, 149-158.
121. Jia, X., Hollung, K., Therkildsen, M., Hildrum, K. I., Bendixen, E., Proteome analysis of early post-mortem changes in two bovine muscle types: M. longissimus dorsi and M. semitendinosis. Proteomics 2006, 6, 936-944.
122. Lewis, C., Carberry, S., Ohlendieck, K., Proteomic profiling of x-linked muscular dystrophy. J. Muscle Res. Cell. Motil. 2009, 30, 267-269.
123. Hunsucker, S. W., Accurso, F. J., Duncan, M. W., Proteomics in pediatric research and practice. Adv. Pediatr. 2007, 54, 9-28.
124. Savage, W. J., Everett, A. D., Biomarkers in pediatrics: children as biomarker orphans. Proteomics Clin. Appl. 2010, 4, 915-921.
125. Buijs, E. A., Zwiers, A. J., Ista, E., Tibboel, D., de Wildt, S. N., Biomarkers and clinical tools in critically ill children: are we heading toward tailored drug therapy? Biomark. Med. 2012, 6, 239-257.
126. Young, J., Stone, W. L., Pediatric proteomics: an introduction. Front. Biosci. 2012, 4, 1078-1087.
127. Muntoni, F., Torelli, S., Ferlini, A., Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol. 2003, 2, 731-740.
128. Koenig, M., Hoffman, E. P., Bertelson, C. J., Monaco, A. P. et al., Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987, 50, 509-517.
129. Hoffman, E. P., Brown, R. H., Jr., Kunkel, L. M., Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51, 919-928.
130. Koenig, M., Beggs, A. H., Moyer, M., Scherpf, S. et al., The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am. J. Hum. Genet. 1989, 45, 498-506.
131. Dalkilic, I., Kunkel, L. M. Muscular dystrophies: genes to pathogenesis. Curr. Opin. Genet. Dev. 2003, 13, 231-238.
132. Campbell, K. P., Kahl, S. D., Association of dystrophin and an integral membrane glycoprotein. Nature 1989, 338, 259-262.
133. Yoshida, M., Ozawa, E., Glycoprotein complex anchoring dystrophin to sarcolemma. J. Biochem. 1990, 108, 748-752.
134. Ervasti, J. M., Campbell, K. P., A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 1993, 122, 809-823.
135. Ervasti, J. M., Ohlendieck, K., Kahl, S. D., Gaver, M. G., Campbell, K. P., Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 1990, 345, 315-319.
136. Ohlendieck, K., Matsumura, K., Ionasescu, V. V., Towbin, J. A. et al., Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma. Neurology 1993, 43, 795-800.
137. Ohlendieck, K., Campbell, K. P., Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J. Cell. Biol. 1991, 115, 1685-1694.
138. Menke, A., Jockusch, H., Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse. Nature 1991, 349, 69-71.
139. Menke, A., Jockusch, H., Extent of shock-induced membrane leakage in human and mouse myotubes depends on dystrophin. J. Cell Sci. 1995, 108, 727-733.
140. Lynch, G. S., Rafael, J. A., Chamberlain, J. S., Faulkner, J. A., Contraction-induced injury to single permeabilized muscle fibers from mdx, transgenic mdx, and control mice. Am. J. Physiol. Cell. Physiol. 2000, 279, C1290-C1294.
141. De Luca, A., Pierno, S., Liantonio, A., Cetrone, M. et al., Alteration of excitation-contraction coupling mechanism in extensor digitorum longus muscle fibres of dystrophic mdx mouse and potential efficacy of taurine. Br. J. Pharmacol. 2001, 132, 1047-1054.
142. 2+ signaling. Am. J. Physiol. Cell Physiol. 2009, 297, C571-C580.
143. Capote, J., DiFranco, M., Vergara, J. L., Excitation-contraction coupling alterations in mdx and utrophin/dystrophin double knockout mice: a comparative study. Am. J. Physiol. Cell Physiol. 2010, 298, C1077-C1086.
144. Culligan, K., Banville, N., Dowling, P., Ohlendieck, K., Drastic reduction of calsequestrin-like proteins and impaired calcium binding in dystrophic mdx muscle. J. Appl. Physiol. 2002, 92, 435-445.
145. Dowling, P., Doran, P., Ohlendieck, K., Drastic reduction of sarcalumenin in Dp427 (dystrophin of 427 kDa)-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy. Biochem. J. 2004, 379, 479-488.
146. 2+-binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle. Eur. J. Biochem. 2004, 271, 3943-3952.
147. Tutdibi, O., Brinkmeier, H., Rüdel, R., Föhr, K. J., Increased calcium entry into dystrophin-deficient muscle fibres of MDX and ADR-MDX mice is reduced by ion channel blockers. J. Physiol. 1999, 515, 859-868.
148. Allen, D. G., Gervasio, O. L., Yeung, E. W., Whitehead, N. P., Calcium and the damage pathways in muscular dystrophy. Can. J. Physiol. Pharmacol. 2010, 88, 83-91.
149. 2+ entry in dystrophic mdx mouse muscle. Am. J. Physiol. Cell Physiol. 2010, 299, C42-C50.
150. Alderton, J. M., Steinhardt, R. A., Calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. J. Biol. Chem. 2000, 275, 452-460.
151. + channels. Proc. Natl. Acad. Sci. USA 2000, 97, 4950-4955.
152. Krüger, J., Kunert-Keil, C., Bisping, F., Brinkmeier, H., Transient receptor potential cation channels in normal and dystrophic mdx muscle. Neuromuscul. Disord. 2008, 18, 501-513.
153. Turner, P. R., Westwood, T., Regen, C. M., Steinhardt, R. A., Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature 1988, 335, 735-738.
154. Alderton, J. M., Steinhardt, R. A., How calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. Trends Cardiovasc. Med. 2000, 10, 268-272.
155. Lewis, C., Ohlendieck, K., Mass spectrometric identification of dystrophin isoform Dp427 by on-membrane digestion of sarcolemma from skeletal muscle. Anal. Biochem. 2010, 404, 197-203.
156. Yoon, J. H., Johnson, E., Xu, R., Martin, L. T., Comparative proteomic profiling of dystroglycan-associated proteins in wild type, mdx, and Galgt2 transgenic mouse skeletal muscle. J. Proteome Res. 2012, 11, 4413-4424.
157. Johnson, E. K., Zhang, L., Adams, M. E., Phillips, A. et al., Proteomic analysis reveals new cardiac-specific dystrophin-associated proteins. PLoS One 2012, 7, e43515.
158. Ge, Y., Molloy, M. P., Chamberlain, J. S., Andrews, P. C., Proteomic analysis of mdx skeletal muscle: great reduction of adenylate kinase 1 expression and enzymatic activity. Proteomics 2003, 3, 1895-1903.
159. Ge, Y., Molloy, M. P., Chamberlain, J. S., Andrews, P. C., Differential expression of the skeletal muscle proteome in mdx mice at different ages. Electrophoresis 2004, 25, 2576-2585.
160. Doran, P., Dowling, P., Donoghue, P., Buffini, M., Ohlendieck, K., Reduced expression of regucalcin in young and aged mdx diaphragm indicates abnormal cytosolic calcium handling in dystrophin-deficient muscle. Biochim. Biophys. Acta 2006, 1764, 773-785.
161. Gardan-Salmon, D., Dixon, J. M., Lonergan, S. M., Selsby, J. T., Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice. Eur. J. Appl. Physiol. 2011, 111, 2763-2773.
162. Rayavarapu, S., Coley, W., Cakir, E., Jahnke, V. et al., Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse. Mol. Cell. Proteomics 2013, 12, 1061-1073.
163. Doran, P., Martin, G., Dowling, P., Jockusch, H., Ohlendieck, K., Proteome analysis of the dystrophin-deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHSP. Proteomics 2006, 6, 4610-4621.
164. Doran, P., Wilton, S. D., Fletcher, S., Ohlendieck, K., Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm. Proteomics 2009, 9, 671-685.
165. Carberry, S., Zweyer, M., Swandulla, D., Ohlendieck, K., Application of fluorescence two-dimensional difference in-gel electrophoresis as a proteomic biomarker discovery tool in muscular dystrophy research. Biology 2013, 2, 1438-1464.
166. Matsumura, C. Y., Menezes de Oliveira, B., Durbeej, M., Marques, M. J., Isobaric tagging-based quantification for proteomic analysis: a comparative study of spared and affected muscles from mdx mice at the early phase of dystrophy. PLoS One 2013, 8, e65831.
167. Lewis, C., Ohlendieck, K., Proteomic profiling of naturally protected extraocular muscles from the dystrophin-deficient mdx mouse. Biochem. Biophys. Res. Commun. 2010, 396, 1024-1029.
168. Carberry, S., Brinkmeier, H., Zhang, Y., Winkler, C. K., Ohlendieck, K., Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy. Int. J. Mol. Med. 2013, 32, 544-556.
169. Carberry, S., Zweyer, M., Swandulla, D., Ohlendieck, K., Comparative proteomic analysis of the contractile protein-depleted fraction from normal versus dystrophic skeletal muscle. Anal. Biochem. 2014, 446, 108-115.
170. Alagaratnam, S., Mertens, B. J., Dalebout, J. C., Deelder, A. M. et al., Serum protein profiling in mice: identification of Factor XIIIa as a potential biomarker for muscular dystrophy. Proteomics 2008, 8, 1552-1563.
171. Colussi, C. Banfi, C., Brioschi, M. Tremoli, E. et al., Proteomic profile of differentially expressed plasma proteins from dystrophic mice and following suberoylanilide hydroxamic acid treatment. Proteomics Clin. Appl. 2010, 4, 71-83.
172. Nadarajah, V. D., van Putten, M., Chaouch, A., Garrood, P. et al., Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD). Neuromuscul. Disord. 2011, 21, 569-578.
173. Nadarajah, V. D., Mertens, B. J. A., Dalebout, H., Bladergroen, M. R. et al., Serum peptide profiles of Duchenne muscular dystrophy (DMD) patients evaluated by data handling strategies for high resolution content. J. Proteomics Bioinform. 2012, 5, 4.
174. Martin, F. C., Hiller, M., Spitali, P., Oonk, S. et al., Fibronectin is a serum biomarker for Duchenne muscular dystrophy. Proteomics Clin. Appl. 2014, 8, 269-278.
175. Gulston, M. K., Rubtsov, D. V., Atherton, H. J., Clarke, K. et al., A combined metabolomic and proteomic investigation of the effects of a failure to express dystrophin in the mouse heart. J. Proteome Res. 2008, 7, 2069-2077.
176. Lewis, C., Jockusch, H., Ohlendieck, K., Proteomic profiling of the dystrophin-deficient MDX heart reveals drastically altered levels of key metabolic and contractile proteins. J. Biomed. Biotechnol. 2010, 2010, 648501.
177. Holland, A., Dowling, P., Zweyer, M., Swandulla, D. et al., Proteomic profiling of cardiomyopathic tissue from the aged mdx model of Duchenne muscular dystrophy reveals a drastic decrease in laminin, nidogen and annexin. Proteomics 2013, 13, 2312-2323.
178. Carberry, S., Zweyer, M., Swandulla, D., Ohlendieck, K., Profiling of age-related changes in the tibialis anterior muscle proteome of the mdx mouse model of dystrophinopathy. J. Biomed. Bioeng. 2012, 2012, 691641.
179. Carberry, S., Zweyer, M., Swandulla, D., Ohlendieck, K., Proteomics reveals drastic increase of extracellular matrix proteins collagen and dermatopontin in the aged mdx diaphragm model of Duchenne muscular dystrophy. Int. J. Mol. Med. 2012, 30, 229-234.
180. Duguez, S., Duddy, W., Johnston, H., Lainé, J. et al., Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion. Cell. Mol. Life Sci. 2013, 70, 2159-2174.
181. Guevel, L., Lavoie, J. R., Perez-Iratxeta, C., Rouger, K. et al., Quantitative proteomic analysis of dystrophic dog muscle. J. Proteome Res. 2011, 10, 2465-2478.
182. Ramadasan-Nair, R., Gayathri, N., Mishra, S., Sunitha, B. et al., Mitochondrial alterations and oxidative stress in an acute transient mouse model of muscle degeneration: implications for muscular dystrophy and related muscle pathologies. J. Biol. Chem. 2013, 289, 485-509.
183. Bornman, L., Polla, B. S., Lotz, B. P., Gericke, G. S., Expression of heat-shock/stress proteins in Duchenne muscular dystrophy. Muscle Nerve 1995, 18, 23-31.
184. Paepe, B. D., Creus, K. K., Weis, J., Bleecker, J. L. Heat shock protein families 70 and 90 in Duchenne muscular dystrophy and inflammatory myopathy: balancing muscle protection and destruction. Neuromuscul. Disord. 2012, 22, 26-33.
185. Bornman, L., Rossouw, H., Gericke, G. S., Polla, B. S., Effects of iron deprivation on the pathology and stress protein expression in murine X-linked muscular dystrophy. Biochem. Pharmacol. 1998, 56, 751-757.
186. Gehrig, S. M., van der Poel, C., Sayer, T. A., Schertzer, J. D. et al., Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. Nature 2012, 484, 394-398.
187. Goonasekera, S. A., Lam, C. K., Millay, D. P., Sargent, M. A. et al., Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle. J. Clin. Invest. 2011, 121, 1044-1052.
188. Bouchentouf, M., Benabdallah, B. F., Tremblay, J. P., Myoblast survival enhancement and transplantation success improvement by heat-shock treatment in mdx mice. Transplantation 2004, 77, 1349-1356.
189. Doran, P., Gannon, J., O'Connell, K., Ohlendieck, K., Proteomic profiling of animal models mimicking skeletal muscle disorders. Proteomics Clin. Appl. 2007, 1, 1169-1184.
190. Bulfield, G., Siller, W. G., Wight, P. A., Moore, K. J., X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci USA 1984, 81, 1189-1192.
191. Torres, L. F., Duchen, L. W., The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates. Brain 1987, 110, 269-299.
192. Stedman, H. H., Sweeney, H. L., Shrager, J. B., Maguire, H. C. et al., The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 1991, 352, 536-539.
193. Dowling, P., Culligan, K., Ohlendieck, K., Distal mdx muscle groups exhibiting up-regulation of utrophin and rescue of dystrophin-associated glycoproteins exemplify a protected phenotype in muscular dystrophy. Naturwissenschaften 2002, 89, 75-78.
194. Dowling, P., Lohan, J., Ohlendieck, K., Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of beta-dystroglycan. Eur. J. Cell Biol. 2003, 82, 222-230.
195. Marques, M. J., Ferretti, R., Vomero, V. U., Minatel, E., Neto, H. S., Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy. Muscle Nerve 2007, 35, 349-353.
196. Goldspink, G., Fernandes, K., Williams, P. E., Wells, D. J., Age-related changes in collagen gene expression in the muscles of mdx dystrophic and normal mice. Neuromuscul. Disord. 1994, 4, 183-191.
197. Lefaucheur, J. P., Pastoret, C., Sebille, A., Phenotype of dystrophinopathy in old mdx mice. Anat. Rec. 1995, 242, 70-76.
198. 2+ homeostasis during fatigue. Exp. Physiol. 2010, 95, 641-656.
199. Pastoret, C., Sebille, A., MDX mice show progressive weakness and muscle deterioration with age. J. Neurol. Sci. 1995, 129, 97-105.
200. Lynch, G. S., Hinkle, R. T., Chamberlain, J. S., Brooks, S. V., Faulkner, J. A., Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old. J. Physiol. 2001, 535, 591-600.
201. Chamberlain, J. S., Metzger, J., Reyes, M., Townsend, D., Faulkner, J. A., Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J. 2007, 21, 2195-2204.
202. Mouisel, E., Vignaud, A., Hourde, C., Butler-Browne, G., Ferry, A., Muscle weakness and atrophy are associated with decreased regenerative capacity and changes in mTOR signaling in skeletal muscles of venerable (18-24-month-old) dystrophic mdx mice. Muscle Nerve 2010, 41, 809-818.
203. Wettstein, G., Bellaye, P. S., Micheau, O., Bonniaud, P., Small heat shock proteins and the cytoskeleton: an essential interplay for cell integrity? Int. J. Biochem. Cell Biol. 2012, 44, 1680-1686.
204. Hauerslev, S., Sveen, M. L., Duno, M., Angelini, C. et al., Calpain 3 is important for muscle regeneration: evidence from patients with limb girdle muscular dystrophies. BMC Musculoskelet. Disord. 2012, 13, 43.
205. Vidyasagar, A., Wilson, N. A., Djamali, A., Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target. Fibrogenesis Tissue Repair 2012, 5, 7.
206. Fittipaldi, S., Dimauro, I., Mercatelli, N., Caporossi, D., Role of exercise-induced reactive oxygen species in the modulation of heat shock protein response. Free Radic. Res. 2014, 48, 52-70.
207. Rando, T. A., Oxidative stress and the pathogenesis of muscular dystrophies. Am. J. Phys. Med. Rehabil. 2002, 81, S175-S186.
208. Dowling, P., Doran, P., Lohan, J., Culligan, K., Ohlendieck, K., Naturally protected muscle phenotypes: development of novel treatment strategies for Duchenne muscular dystrophy. Basic Appl. Myol. 2004, 14, 169-177.
209. Zeiger, U., Mitchell, C. H., Khurana, T. S., Superior calcium homeostasis of extraocular muscles. Exp. Eye Res. 2010, 91, 613-622.
210. Mosqueira, M., Zeiger, U., Förderer, M., Brinkmeier, H., Fink, R. H., Cardiac and respiratory dysfunction in Duchenne muscular dystrophy and the role of second messengers. Med. Res. Rev. 2013, 33, 1174-1213.
211. Frankel, K. A., Rosser, R. J. The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. Hum. Pathol. 1976, 7, 375-386.
212. Finsterer, J., Stollberger, C., The heart in human dystrophinopathies. Cardiology 2003, 99, 1-19.
213. Romfh, A., McNally, E. M., Cardiac assessment in Duchenne and Becker muscular dystrophies. Curr. Heart Fail. Rep. 2010, 7, 212-218.
214. Banks, G. B., Chamberlain, J. S., The value of mammalian models for Duchenne muscular dystrophy in developing therapeutic strategies. Curr. Top. Dev. Biol. 2008, 84, 431-453.
215. Spurney, C. F., Gordish-Dressman, H., Guerron, A. D., Sali, A. et al., Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures. Muscle Nerve 2009, 39, 591-602.
216. De Luca, A., Pre-clinical drug tests in the mdx mouse as a model of dystrophinopathies: an overview. Acta Myol. 2012, 31, 40-47.
217. Mitrpant, C., Fletcher, S., Wilton, S. D., Personalised genetic intervention for Duchenne muscular dystrophy: antisense oligomers and exon skipping. Curr. Mol. Pharmacol. 2009, 2, 110-121.
218. Lu, Q. L., Yokota, T., Takeda, S., Garcia, L. et al., The status of exon skipping as a therapeutic approach to Duchenne muscular dystrophy. Mol. Ther. 2011, 19, 9-15.
219. Arechavala-Gomeza, V., Anthony, K., Morgan, J., Muntoni, F., Antisense oligonucleotide-mediated exon skipping for Duchenne muscular dystrophy: progress and challenges. Curr. Gene Ther. 2012, 12, 152-160.
220. Fairclough, R. J., Wood, M. J., Davies, K. E., Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches. Nat. Rev. Genet. 2013, 14, 373-378.
221. Koo, T., Wood, M. J., Clinical trials using antisense oligonucleotides in Duchenne muscular dystrophy. Hum. Gene Ther. 2013, 24, 479-488.
222. Kinali, M., Arechavala-Gomeza, V., Feng, L., Cirak, S. et al., Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol. 2009, 8, 918-928.
223. Goemans, N. M., Tulinius, M., van den Akker, J. T., Burm, B. E. et al., Systemic administration of PRO051 in Duchenne's muscular dystrophy. N. Engl. J. Med. 2011, 364, 1513-1522.
224. Cirak, S., Arechavala-Gomeza, V., Guglieri, M., Feng, L. et al., Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet 2011, 378, 595-605.
225. Partridge, T. A., Impending therapies for Duchenne muscular dystrophy. Curr. Opin. Neurol. 2011, 24, 415-422.
226. Stastna, M., Van Eyk, J. E., Secreted proteins as a fundamental source for biomarker discovery. Proteomics 2012, 12, 722-735.
227. Sun, G., Haginoya, K., Chiba, Y., Uematsu, M. et al., Elevated plasma levels of tissue inhibitors of metalloproteinase-1 and their overexpression in muscle in human and mouse muscular dystrophy. J. Neurol. Sci. 2010, 297, 19-28.
228. D'Amore, P. A., Brown, R. H., Jr., Ku, P. T., Hoffman, E. P. et al., Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy. Ann. Neurol. 1994, 35, 362-365.
229. Bernasconi, P., Torchiana, E., Confalonieri, P., Brugnoni, R. et al., Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. J. Clin. Invest. 1995, 96, 1137-1144.
230. Ishitobi, M., Haginoya, K., Zhao, Y., Ohnuma, A. et al., Elevated plasma levels of transforming growth factor beta1 in patients with muscular dystrophy. Neuroreport 2000, 11, 4033-4035.
231. von Moers, A., Danne, T., Möller, P., Scheffner, D. et al., Serum levels of carboxyterminal propeptide of type I procollagen, aminoterminal propeptide of type III procollagen and laminin P1 in Duchenne muscular dystrophy. Acta Paediatr. 1997, 86, 377-380.
232. Chiu, T. F., Li, C. H., Chen, C. C., Chen, C. H. et al., Association of plasma concentration of small heat shock protein B7 with acute coronary syndrome. Circ. J. 2012, 76, 2226-2233.
233. Heidari-Bakavoli, A. R., Sahebkar, A., Mobara, N., Moohebati, M. et al., Changes in plasma level of heat shock protein 27 after acute coronary syndrome. Angiology 2012, 63, 12-16.
234. Ogawa, K., Kim, H. K., Shimizu, T., Abe, S. et al., Plasma heat shock protein 72 as a biomarker of sarcopenia in elderly people. Cell Stress Chaperones 2012, 17, 349-359.